117 related articles for article (PubMed ID: 31413588)
1. Estradiol promotes the progression of ER+ breast cancer through methylation-mediated RSK4 inactivation.
Li Q; Gao H; Yang H; Wei W; Jiang Y
Onco Targets Ther; 2019; 12():5907-5916. PubMed ID: 31413588
[No Abstract] [Full Text] [Related]
2. RSK4 inhibits breast cancer cell proliferation and invasion in vitro, and is correlated with estrogen receptor upregulation in breast cancer.
Huo H; Ye X; Yang H; Li Q; Jiang Y
Oncol Rep; 2019 Dec; 42(6):2777-2787. PubMed ID: 31545499
[TBL] [Abstract][Full Text] [Related]
3. Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer.
Li Q; Jiang Y; Wei W; Ji Y; Gao H; Liu J
Med Oncol; 2014 Jan; 31(1):793. PubMed ID: 24338215
[TBL] [Abstract][Full Text] [Related]
4. RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells.
Zhu J; Li QY; Liu JL; Wei W; Yang HW; Tang W
Oncol Rep; 2015 Dec; 34(6):3156-62. PubMed ID: 26397146
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer.
Arechavaleta-Velasco F; Dominguez-Lopez P; Acosta-Jimenez E; Diaz-Cueto L
Mol Biol Rep; 2023 Aug; 50(8):6863-6870. PubMed ID: 37402066
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of RSK4 in breast cancer and its role in the regulation of tumorigenicity.
Jiang Y; Ye X; Ji Y; Zhou X; Yang H; Wei W; Li Q
Int J Mol Med; 2017 Sep; 40(3):883-890. PubMed ID: 28731146
[TBL] [Abstract][Full Text] [Related]
7. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells.
Thakur A; Sun Y; Bollig A; Wu J; Biliran H; Banerjee S; Sarkar FH; Liao DJ
Clin Cancer Res; 2008 Jul; 14(14):4427-36. PubMed ID: 18628456
[TBL] [Abstract][Full Text] [Related]
8. Effect of RSK4 on Biological Characteristics of Gastric Cancer.
Hu C; Dai J; Lin X; Meng Y; Liang H
Cancer Manag Res; 2020; 12():611-619. PubMed ID: 32095082
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
Zhu L; Zhang S; Huan X; Mei Y; Yang H
Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
[TBL] [Abstract][Full Text] [Related]
10. Effect of RSK4 on biological characteristics of colorectal cancer.
Ye Q; Wang X; Jin M; Wang M; Hu Y; Yu S; Yang Y; Yang J; Cai J
World J Surg Oncol; 2018 Dec; 16(1):240. PubMed ID: 30579335
[TBL] [Abstract][Full Text] [Related]
11. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.
Song P; Li Y; Dong Y; Liang Y; Qu H; Qi D; Lu Y; Jin X; Guo Y; Jia Y; Wang X; Xu W; Quan C
J Exp Clin Cancer Res; 2019 Aug; 38(1):354. PubMed ID: 31412908
[TBL] [Abstract][Full Text] [Related]
13. Effect of pyruvate kinase M2-regulating aerobic glycolysis on chemotherapy resistance of estrogen receptor-positive breast cancer.
Qian Y; Bi L; Yang Y; Wang D
Anticancer Drugs; 2018 Aug; 29(7):616-627. PubMed ID: 29782350
[TBL] [Abstract][Full Text] [Related]
14. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
15. Raltitrexed regulates proliferation and apoptosis of HGC-27 cells by upregulating RSK4.
Hu C; Chen X; Lin X; Dai J; Yu J
BMC Pharmacol Toxicol; 2022 Aug; 23(1):65. PubMed ID: 36031631
[TBL] [Abstract][Full Text] [Related]
16. COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells.
Le Dily F; Métivier R; Guéguen MM; Le Péron C; Flouriot G; Tas P; Pakdel F
Breast Cancer Res Treat; 2008 Jul; 110(1):69-83. PubMed ID: 17674191
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.
Zhou L; Cai B; Bao W; He YY; Chen XY; Yang YX; Liu XL; Wan XP
Int J Gynecol Cancer; 2011 Nov; 21(8):1357-65. PubMed ID: 21720253
[TBL] [Abstract][Full Text] [Related]
18. H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells.
Sun H; Wang G; Peng Y; Zeng Y; Zhu QN; Li TL; Cai JQ; Zhou HH; Zhu YS
Oncol Rep; 2015 Jun; 33(6):3045-52. PubMed ID: 25846769
[TBL] [Abstract][Full Text] [Related]
19. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.
Yoshida T; Eguchi H; Nakachi K; Tanimoto K; Higashi Y; Suemasu K; Iino Y; Morishita Y; Hayashi S
Carcinogenesis; 2000 Dec; 21(12):2193-201. PubMed ID: 11133808
[TBL] [Abstract][Full Text] [Related]
20. 17β-estradiol promotes the invasion and migration of nuclear estrogen receptor-negative breast cancer cells through cross-talk between GPER1 and CXCR1.
Jiang QF; Wu TT; Yang JY; Dong CR; Wang N; Liu XH; Liu ZM
J Steroid Biochem Mol Biol; 2013 Nov; 138():314-24. PubMed ID: 23907016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
